Dianthus Therapeutics, Inc.: accounts_payable

Value{"amount": 7572000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"}
Period (as of 2024-09-30)
Statuscurrent
EntityDianthus Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-24-123285 · Open the official SEC filing →
Retrieved: 2026-08-19T17:19:32.661739+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001690585/accounts-payable/2024-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/d2af2f07-6d88-40dd-874b-3e48adea72bc

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies